Stay updated on GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial
Sign up to get notified when there's something new on the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page.

Latest updates to the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedAdded revision v3.6.3 to the Record History and removed revision v3.6.2. This updates the page’s version history to reflect the latest release.SummaryDifference0.1%

- Check18 days agoChange DetectedThe page now includes an expanded footer with official site links and branding, and the record history section lists past versions and their submission dates.SummaryDifference34%

- Check33 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', indicating enrollment is closed. The page now shows a new release version 'Revision: v3.6.0', replacing the previous 'v3.5.5'.SummaryDifference0.4%

- Check40 days agoChange DetectedA new revision entry, v3.5.5, has been added to the history, replacing the previous revision v3.5.4. This reflects a minor internal update to the site's history presentation.SummaryDifference0.1%

- Check61 days agoChange DetectedThe Record History now lists Revision: v3.5.4 as the latest release, replacing the previous v3.5.3. This reflects a routine site update rather than changes to study records.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3, indicating a UI or system release with no change to the underlying study record fields.SummaryDifference0.1%

Stay in the know with updates to GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page.